Results 31 to 40 of about 14,561,710 (295)

Acceleration of cutaneous T-cell lymphoma following dupilumab administration

JAAD Case Reports, 2020
CTCL: cutaneous T-cell lymphoma IL: interleukin INTRODUCTION Recent advances in the treatment of moderate-tosevere atopic dermatitis have led to increased use of dupilumab, which is a human monoclonal antibody that binds to the interleukin (IL) 4 ...
K. Russomanno, Cynthia Marie Carver DeKlotz   +1 more
semanticscholar   +1 more source

Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma : endpoints of a spectrum of one disease? [PDF]

, 2013
In contrast to the commonly indolent clinical behavior of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), T cell/histiocyte rich large B cell lymphoma (THRLBCL) is frequently diagnosed in advanced clinical stages and has a poor prognosis ...
Benjamin Rengstl, Sebastian Newrzela, Randy Gascoyne, Xavier Sagaert (482298), Xavier Sagaert, Hartmann, Sylvia, Martin-Leo Hansmann, Claudia Döring, Küppers, Ralf, Chris de Wolf-Peeters, Fabio Facchetti, Ralf Küppers, Fabio Facchetti (376587), Sylvia Hartmann, Rengstl, Benjamin, Hansmann, Martin-Leo, Christian Steidl, Sagaert, Xavier, Martin-Leo Hansmann (260067), Tousseyn, Thomas, Christian Steidl (482300), Ralf Küppers (260072), Thomas Tousseyn (482297), Chris de Wolf-Peeters (482299), Steidl, Christian, Claudia Döring (474984), Ponzoni, Maurilio, Randy Gascoyne (482301), Jakobus, Christina, Wolf-Peeters, Chris de, Benjamin Rengstl (482295), Sebastian Newrzela (482296), Gascoyne, Randy, Maurilio Ponzoni (126480), Döring, Claudia, Thomas Tousseyn, Christina Jakobus (482294), Christina Jakobus, Facchetti, Fabio, Sylvia Hartmann (260069), Newrzela, Sebastian, Maurilio Ponzoni   +41 more
core   +2 more sources

Cutaneous Involvement of Extranodal NK/T Cell Lymphoma, Nasal Type, a Clinical and Histopathological Mimicker of Various Skin Diseases

Dermatopathology, 2022
Background: Extranodal NK/T cell lymphoma, nasal type (ENK/T) with cutaneous involvement has various histopathological findings and diverse clinical manifestations.
Preeyawat Ngamdamrongkiat, Sanya Sukpanichnant, Manasmon Chairatchaneeboon, Archrob Khuhapinant, Panitta Sitthinamsuwan   +4 more
doaj   +1 more source

The impact of molecular alterations and the immune microenvironment on the natural history of Follicular Lymphoma including transformation to Diffuse Large B cell Lymphoma [PDF]

, 2009
PhDThe natural history of follicular lymphoma is heterogeneous with numerous relapses and remissions over many years. A substantial number of patients suffer an aggressive disease course with death due to disease within 5 years of diagnosis.
Lee, Abigail Mary
core   +4 more sources

Therapeutic Efficacy of Etretinate on Cutaneous-type Adult T-cell Leukemia-Lymphoma

Acta Dermato-Venereologica, 2019
Cutaneous-type adult T-cell leukemia-lymphoma is treated with antiviral or skin-directed therapy. Medications that are used to treat skin lesions of cutaneous T-cell lymphomas are also used for the cutaneous-type adult T-cell leukemia-lymphoma ...
Kentaro Yonekura, Koichiro Takeda, Nobuyo Kawakami, Tamotsu Kanzaki, Takuro Kanekura, Atae Utsunomiya   +5 more
doaj   +1 more source

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

The Lancet Oncology, 2018
BACKGROUND Cutaneous T-cell lymphomas are rare non-Hodgkin lymphomas with substantial morbidity and mortality in advanced disease stages. We compared the efficacy of mogamulizumab, a novel monoclonal antibody directed against C-C chemokine receptor 4 ...
Youn H. Kim, M. Bagot, L. Pinter-Brown, A. Rook, P. Porcu, S. Horwitz, S. Whittaker, Y. Tokura, M. Vermeer, P. Zinzani, L. Sokol, S. Morris, Ellen J. Kim, P. Ortiz-Romero, H. Eradat, J. Scarisbrick, A. Tsianakas, C. Elmets, S. Dalle, D. Fisher, A. Halwani, B. Poligone, J. Greer, M. Fierro, A. Khot, A. Moskowitz, A. Musiek, A. Shustov, B. Pro, L. Geskin, K. Dwyer, J. Moriya, M. Leoni, J. Humphrey, S. Hudgens, Dmitri O. Grebennik, K. Tobinai, M. Duvic, Sunil Abhyankar, Oleg E. Akilov, Onder Alpdogan, M. Beylot-Barry, E. Boh, D. Caballero, R. Cowan, B. Dréno, R. Dummer, T. Fenske, F. Foss, Noriko Fukuhara, P. Giri, Koji Habe, T. Hamada, K. Hatake, S. Iida, Osamu Ishikawa, L. Iversen, Eiji Kiyohara, H. Koga, N. Korman, B. Kuss, Zanetta Lamar, Frederick Lansigan, M. Lechowicz, Adam Lerner, Nina Magnolo, L. Mark, T. Miyagaki, J. Muñoz, J. P. Nicolay, Kaoru Nishiwaki, H. Okamoto, M. Ohtsuka, T. Pacheco, C. Querfeld, Ronald Peter Rapini, Shigetoshi Sano, Maiko Tanaka, Michael D. Tharp, J. Uehara, H. Wada, J. Wells, R. Wilcox, B. William, Kentaro Yonekura   +84 more
semanticscholar   +1 more source

Cutaneous anaplastic large T-cell lymphoma in a cat - case report [PDF]

Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2023
Lymphoma is the most common lymphoproliferative disorder in cats. However, cutaneous lymphomas are uncommon in this species and can be classified as epitheliotropic or non-epitheliotropic.
R.D. Mazaro, D.M. Lorenzetti, M.B. Beckenkamp, T.C. Silva, B. Cogliati, R.A. Fighera   +5 more
doaj   +1 more source

Distribution and clinical features of lymphomas involving skin in Taiwan

Kaohsiung Journal of Medical Sciences, 2023
A wide variety of primary and secondary lymphoma types involves the skin. However, reports with comparisons between both groups are limited in Taiwan.
Cheng‐Lin Wu, Su‐Wei Chang, Julia Yu‐Yun Lee, Tsai‐Yun Chen, Chien‐Chin Chen, Chia‐Bao Chu, L. Jeffrey Medeiros, Kung‐Chao Chang   +7 more
doaj   +1 more source

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.

The Lancet Oncology, 2019
BACKGROUND IPH4102 is a first-in-class monoclonal antibody targeting KIR3DL2, a cell surface protein that is expressed in cutaneous T-cell lymphoma, and predominantly in its leukaemic form, Sézary syndrome.
M. Bagot, P. Porcu, A. Marie-Cardine, M. Battistella, B. William, M. Vermeer, S. Whittaker, F. Rotolo, C. Ram-Wolff, M. Khodadoust, A. Bensussan, C. Paturel, C. Bonnafous, H. Sicard, H. Azim, Youn H. Kim   +15 more
semanticscholar   +1 more source

Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma.

Blood, 2019
It has been proposed that CD4 T cell responses to Staphylococcus aureus (SA) can inadvertently enhance neoplastic progression in models of skin cancer and cutaneous T cell lymphoma (CTCL).
L. Lindahl, A. Willerslev-Olsen, L. Gjerdrum, P. R. Nielsen, Edda P. Blümel, A. H. Rittig, Pamela Celis, B. Herpers, J. Becker, B. Stausbøl‐Grøn, M. Wasik, Maria Gluud, Simon Fredholm, T. B. Buus, C. Johansen, C. Nastasi, Lukas Peiffer, Linda Kubat, M. Bzorek, J. Eriksen, T. Krejsgaard, C. Bonefeld, C. Geisler, T. Mustelin, E. Langhoff, M. Givskov, A. Woetmann, M. Kilian, T. Litman, L. Iversen, N. Odum   +30 more
semanticscholar   +1 more source